# Avantika Gupta

> Avantika Gupta is a seed investor at Type One Ventures backing Artificial Intelligence. See 9 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Type One Ventures](https://shizune.co/investors/profile/type-1-ventures)
- Location: London, United Kingdom
- Total investments: 9
- Last investment: Jun 2025
- Lead investor: 22%
- Last updated: Aug 2026
- LinkedIn: https://uk.linkedin.com/in/avantika-gupta-4a837142

Avantika Gupta is a seed investor at Type One Ventures in London focused on Artificial Intelligence and Biotechnology. Avantika Gupta

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Artificial Intelligence | 3 | 33% |
| Biotechnology | 2 | 22% |
| SaaS | 1 | 11% |
| Music | 1 | 11% |
| Sales | 1 | 11% |

22 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 33% |
| Series A | 3 | 33% |
| Venture - Series Unknown | 1 | 11% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 5 | 56% |
| United States | 2 | 22% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Mandolin | Mandolin is a digital platform designed to help artists, venues, and fans connect through live music. The platform facilitates and offers content creation, distribution, live-streaming of music shows and events and fans' insights, enabling the music community to bring live music back to the stage. | $40M | Series A | Jun 25, 2025 |  |
| Mandolin | Mandolin delivers precision automation tools for specialty drug processing workflows. It automates the full end-to-end lifecycle of tasks such as intake & onboarding (reading referral forms, lab reports, clinical notes), benefits verification (navigating payer portals and extracting eligibility data), patient out-of-pocket estimation, medicalpolicy review and prior authorizations, and claims status plus appeals. Mandolin uses AI agents to perform many of the manual, repetitive tasks that typically occupy back-office teams. It ensures that every action is transparent, logged, and aligned with healthcare payer requirements and regulatory standards. | $40M | Series A | Jun 25, 2025 |  |
| ToffeeX | TOffeeAM optimizes product designs for 3D printing. TOffeeAM creates structures within smart industrial production, such as coolant systems for gas turbines exceeding the performance of current heat exchangers. | $5.8M | Series A | Nov 08, 2022 |  |
| ToffeeX | TOffeeAM optimizes product designs for 3D printing. TOffeeAM creates structures within smart industrial production, such as coolant systems for gas turbines exceeding the performance of current heat exchangers. |  | Series A | Aug 01, 2022 |  |
| NuVision | NuVision™ is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. Dr Andrew Hopkinson, the Principal Research Fellow in Academic Ophthalmology, Division of Clinical Neuroscience at theUniversity of Nottingham, founded NuVision™. The business is co-owned by the founders, Dr Andrew Hopkinson (Chief Scientific Officer), Professor Harminder Dua (co-founder), the directors Mr Byran Lister (CEO) and Dr Helen Shaw (Chairman), and the University of Nottingham. | $2.5M | Venture - Series Unknown | Jul 16, 2021 |  |
| NuVision | NuVision™ is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. Dr Andrew Hopkinson, the Principal Research Fellow in Academic Ophthalmology, Division of Clinical Neuroscience at theUniversity of Nottingham, founded NuVision™. The business is co-owned by the founders, Dr Andrew Hopkinson (Chief Scientific Officer), Professor Harminder Dua (co-founder), the directors Mr Byran Lister (CEO) and Dr Helen Shaw (Chairman), and the University of Nottingham. | $2.2M | Venture - Series Unknown | Apr 22, 2021 |  |
| Zentraxa | Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent previously existingbio-design limits imposed by conventional peptide synthesis, with one universal process. |  | Seed | Apr 22, 2021 |  |
| Elemendar | Elemendar is building Artificial Intelligence that reads cyber threat reports by humans and turns them into industry-standard structured information. |  | Seed | Dec 05, 2020 |  |
| Kluster | Kluster is at the forefront of predictive sales analytics. Harnessing the advanced modeling technology available, they give partners the tools to close more opportunities and forecast more accurately than ever before.Businesses have been tirelessly logging data on their CRMs for years. Kluster Intelligence turns this data into actionable insightsspecifically geared towards commercial gain. Intelligent reporting: comprehensive, flexible, pre-built reporting specifically for salespeople.Opportunity Management: Prioritise the right opportunities, identify those at risk, and continually monitor the top-level pipeline.Predictive Forecasting: Utilise sophisticated machine learning to produce live and accurate sales forecasts. | $1M | Seed | Apr 30, 2020 |  |

9 of 9 investments shown.

## Co-investors
- [IQ Capital](https://shizune.co/investors/profile/iq-capital-partners) — VC Fund, 4 deals together
- [Greylock](https://shizune.co/investors/profile/greylock) — VC Fund, 3 deals together
- [Presidio Ventures](https://shizune.co/investors/profile/presidio-ventures) — VC Fund, 3 deals together
- [SignalFire](https://shizune.co/investors/profile/signal-fire) — VC Fund, 3 deals together
- [Timeless](https://shizune.co/investors/profile/timeless-8d35) — VC Fund, 3 deals together
- [Excellis](https://shizune.co/investors/profile/excellis) — VC Fund, 2 deals together

## About Type One Ventures

VC Fund · Los Angeles, United States

Type One Ventures invests in early-stage startups developing technology, infrastructure, and services. Type One Ventures empowers the entrepreneurs providing the technology, infrastructure, and services that will be integral to the growth and advancement of mankind.

4 contacts available at Type One Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Daniil Chen | Principal | https://shizune.co/investors/profile/daniil-chen |
| Abdo John Hajj | General Partner | https://shizune.co/investors/profile/abdo-john-hajj |
| Avantika Gupta | VP, UK & Europe | https://shizune.co/investors/profile/avantika-gupta |
| Tarek Waked | Founding Partner | https://shizune.co/investors/profile/tarek-waked |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Avantika Gupta invest in?

Avantika Gupta invests primarily in Artificial Intelligence, Biotechnology and SaaS startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Avantika Gupta last invest?

The most recent investment recorded for Avantika Gupta closed in Jun 2025. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co